Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamycin in Children With Familial Adenomatous Polyposis
NCT06308445Phase 2Not yet recruiting
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Sep 2026
- Primary completion
- Sep 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in familial adenomatous polyposis (FAP), sponsored by Centre hospitalier universitaire de Toulouse. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
sirolimus
03
Conditions
familial adenomatous polyposis (FAP)
Beyond the preview
Go deeper on NCT06308445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06308445.